Cytokines, proteins that are secreted by many cells, including inflammatory and glial cells, mediate interactions between cells, generally through paracrine and autocrine networks. Their effects are highly pleiotropic, with overlap of some activities. The pathogenesis of Guillain-Barré syndrome (GBS), especially the classic inflammatory demyelinating polyneuropathy form, seems to involve lymphocytes and macrophages, which are rich sources of cytokines. Macrophages likely have a role in the pathogenesis of the primarily axonal, less inflammatory forms of GBS. Cytokines appear to be involved in damage to Schwann cells, myelin, and axons, although the exact roles of the different cytokines is uncertain. There is increasing evidence that cytokines, including some proinflammatory cytokines that ordinarily cause damage, may also protect the cells of the peripheral nervous system and aid in its repair. The evolution of inflammatory and demyelinating disorders, including the degree of recovery, is probably dependent on the interactions of the different cytokines.
There is increasing interest in the effect of cytokines, proneurons to glial cell differentiation and synthesis of myelinotypic proteins and glycolipids. teins secreted by cells that act at short distances on the same or other cell types (paracrine) or on the same cell (autocrine) There is interest in the relation of cytokines, many of which are produced by inflammatory and immune system cells (aland glial cells [1 -3] . There is extensive literature about cytokine interactions with central nervous system (CNS) glia, inthough clearly not exclusively by these cells), and Schwann cells in inflammatory demyelinating neuropathies, such as the cluding the macroglia (oligodendrocytes and astrocytes) and microglia; the data were determined on the basis of in vitro common demyelinating form of Guillain-Barré syndrome (GBS), acute inflammatory demyelinating polyneuropathy with and in vivo techniques and the study of pathologic material from the brains and spinal cords of patients with neurologic or without significant secondary axonal degeneration, and chronic inflammatory demyelinating polyneuropathy [8] . Howdisease [3 -6] . These studies have increased our understanding of the events occurring in target tissue in diseases such as ever, because inflammatory cells, especially macrophages [9 -12] , are important in traumatic injuries of nerves, in degeneramultiple sclerosis, in CNS manifestations of human immunodeficiency virus infection, and in degenerative diseases, such as tive neuropathies and in inflammatory and immune axonal neuropathies (e.g., the axonal forms of the GBS: acute motorAlzheimer's disease. In turn, this increased understanding has provided new and imaginative therapeutic strategies and insensory axonal neuropathy and acute motor axonal neuropathy), cytokines may also be important in many diseases of the creased the understanding of current therapies even though the etiology of these disorders is unknown.
PNS. The macrophage and its products are important even if they are in response to an antibody-mediated immune reaction There have been far fewer studies on the effects of cytokines and the lower-molecular-mass chemokines [7] on the glial cell or to a chemotactic signal that has no antigen specificity instead of to a cell-mediated immune process. For example, compleof the peripheral nervous system (PNS), the Schwann cell. The Schwann cell is the PNS cell that makes and maintains myelin ment-mediated myelin phagocytosis by macrophages has the potential to increase production of tumor necrosis factor (TNF)-as a modification of its plasma membrane. It has similarities to the myelin-forming cell of the CNS, the oligodendrocyte; a and nitric oxide (NO) [13] , both of which could lead to additional damage in peripheral nerve. however, there are many differences, including the chemical composition of the myelin and the relationship of axons and S174 Lisak et al. JID 1997; 176 (Suppl 2) CD4 / antigen-specific T cells [18] [19] [20] [21] . Schwann cells are not There is no current evidence of a direct toxic effect of TNFa on Schwann cells in vitro, and no toxic effect was noted on ''professional'' antigen-presenting cells and it is not clear if they can contribute to propagation of a T cell immunopathologic Schwann cells in cocultures of Schwann cells and neurons by Mithen et al. [53] . In our culture system, we have not seen any reaction or can suppress such a reaction in vivo, as has been reported in vitro [22] . It is also not clear that there is an in vivo direct toxic effect of TNF-a on Schwann cells. On the other hand, intraneural injection of TNF-a has been reported to incorrelate of Schwann cell MHC class II induction and antigen presentation. In addition, IFN-g and IFN-a/b also up-regulate duce axonal damage or a mixture of damage to axons, myelin, and vascular cells [54] . It has also been reported that TNF-MHC class I antigens [23] , which allows Schwann cells to be targets of cytotoxic antigen-specific T cell reactions, either to a a down-regulates Schwann cell levels of myelin-associated glycoprotein [55] and inhibits Schwann cell proliferation to self-antigen or a microbial antigen infecting the Schwann cell [24] . One difference between purified Schwann cells in vitro certain mitogenic stimuli [56] . IL-1, TNF-a, and IFN-g are highly effective in inducing and the in vivo situation may be the potentially suppressive effect on MHC up-regulation of intact electrophysiologically NO by up-regulating inducible NO synthase. NO has been reported to be synthesized by Schwann cells [22] and is also functional neurons [25] . It is also possible that inhibition of glial cell ion channels could inhibit MHC induction by Schwann potentially toxic to Schwann cells and axons. Cytokines also up-regulate synthesis of prostaglandins and other ecosanoids cells [26] . Although studies in animal models do not usually demonstrate MHC class II molecules on Schwann cells [9, 27- [57], some of which are clearly toxic and proinflammatory and others of which inhibit some of the effects of some of these 32], MHC class II molecules have been reported on Schwann cells in diseased human PNS [33] [34] [35] [36] [37] . MHC antigen induction very same cytokines. As described later, we and others have evidence that Schwann cells themselves can synthesize certain may potentiate nonimmune damage in the nervous system [38] .
It has been shown that IFN-g, interleukin (IL)-1, and TNFcytokines, including IL-1 [58, 59] . The enzyme that converts the inactive form of IL-1b to the active form, IL-1b converting a up-regulate or induce intercellular adhesion molecule-1 (ICAM-1) [20, 39] , which would (as an accessory molecule) enzyme, is important in apoptosis. In addition, Skundric et al. [58, 59] have also found that IL-1 receptor antagonist (ILenhance the role of Schwann cells as antigen-presenting cells for CD4
/ T helper cells responding to either a self-antigen or 1RA), which is known to be made by macrophages and inhibits the effect of both isoforms of IL-1 by competing for binding a microbial antigen. In addition, the presence of ICAM-1 on the Schwann cell surface would also allow a CD8
/ T cell to to the receptors for IL-1 [60] , is also made by Schwann cells.
Since there is evidence that IL-1 has the potential to enhance mediate an antigen-specific cytotoxic reaction [24] . Moreover, adhesion molecules, including ICAM-1, can act as receptors Schwann cell reparative processes (vide infra), production of IL-1RA could prove to be damaging to PNS attempting to for microbes and parasites [40 -42] . It is clear that cytokine induction of adhesion molecules on endothelial cells are critical repair itself. Cytokines may also be important in activating Schwann cells and other glia to secrete complement factors in allowing inflammatory cells to cross the blood-nerve barrier and trigger immune-mediated demyelinating diseases, such as and receptors and proteins that protect cells from the damaging effects of complement [61, 62] . Thus, it is possible that cytoexperimental autoimmune neuritis and, presumably, GBS. It has been reported that in experimental autoimmune neuritis kines could cause damage by contributing to complement production, although if some cytokines induce complement-modivery little, if any, of the ICAM-1 detected in lesions is on Schwann cells [43] , but human peripheral neuropathies have fying factors, these could protect Schwann cells from antibody complement -mediated reactions. not yet been studied extensively.
TNF-a, which is found in lesions of animals with experimenWe and others are examining the effects of cytokines on myelin protein and glycolipid synthesis and myelination and the cellular tal autoimmune neuritis [44] and in the CNS in experimental autoimmune encephalomyelitis and multiple sclerosis [1, 4, 6, and molecular mechanisms that result in demyelination or inhibition of remyelination caused by some of these proteins. Given 45], is widely viewed as being important in inducing demyelination and toxic effects (including direct toxic effects) on oligothe capacity of transforming growth factor (TGF)-b to downregulate activated glial cells, inflammatory cells, and endothelial dendrocytes in CNS diseases [4, 6, 46, 47] . In addition, inhibition of TNF-a inhibits the development of experimental cells, one might expect TGF-b to be protective, as it well may be in experimental autoimmune models [8] . TGF-b has been autoimmune encephalomyelitis and experimental autoimmune neuritis [8, 48, 49] . TNF-a can act in the afferent phase of detected in the PNS in experimental autoimmune neuritis [63] . However, TGF-b can inhibit cAMP-induced Schwann cell suran immune reaction and likely contributes to development of inflammatory and immunopathologic lesions by activating the face galactocerebroside [64] , and it can down-regulate mRNA for Po protein of myelin [64, 65] and up-regulate neural adhesion vascular endothelium [8, 50, 51] and other cells [52] important to the breakdown of the blood-brain or blood-nerve barrier; molecules [64, 66] . The effect of TGF-b on Schwann cells and the synthesis of TGF-b by Schwann cells depends in part on the therefore, a major role for TNF-a may be via changes in the blood vessels rather than by direct or indirect toxic effects on relationship of the Schwann cells to axons and neurites [67] [68] [69] .
We have observed that the ability of TGF-b to inhibit cAMPglial cells and myelin. . In most of our studies, we used human IL-1 and human unfractionated cytokines since purified or recombinant rat ILSchwann cell are induction of apoptosis of damaging or toxic inflammatory cells [8, 22] , induction of surface proteins that pro-1 or antibodies to or sufficiently cross-reactive with rat IL-1 of either isoform were not available. Neither isoform of mouse tect against the effects of cytokines or complement-mediated damage [62] , and induction of protective cytokines or growth factors IL-1, a much closer species to that of the rat, induced rat Schwann cell proliferation [77] . Recently, we have begun to (or both) by Schwann cells or inflammatory cells. In addition, while potentially damaging to Schwann cell production of NO test rat IL-1b, which to date also has not been shown to directly induce significant Schwann cell proliferation. and perinitrite (ONOO Of interest, antibodies to human IL-1a inhibited proliferation, whereas those to IL-1b did not [77] . The explanation for Little is known about such direct or indirect protective effects of cytokines directly involving Schwann cell responses, but this is not clear, although it is known that IL-1a, the more cell-bound isoform, binds with higher avidity to the type I ILcertain growth factors, such as fibroblast growth factor and epidermal growth factor, have protective effects on NO-in-1 receptor [79, 80] . We also found that IL-1RA of human origin also inhibited unfractionated cytokine-induced proliferaduced toxicity in certain neuronal populations [70] . If these mechanisms were active in vivo and could be further enhanced, tion [77] . This not only confirmed the role of IL-1 as a comitogen for Schwann cells but has important physiologic implithey would limit damage to Schwann cells and presumably to myelin. It is well known that certain cytokines can inhibit the cations since IL-1RA, unlike antibodies to IL-1, is part of a regulatory pathway for IL-1 [60, 81] . Indeed it has been shown production and actions of other cytokines within the interactions of inflammatory cells. Thus, Schwann cells or inflammathat inhibition of IL-1 activity by IL-1RA inhibits recovery of rat sciatic nerve subjected to traumatic injury in vivo [82] . tory cells may protect Schwann cells and axons by inhibiting the production or effects of proinflammatory cytokines via the Thus, IL-1, which is often thought of as a proinflammatory or deleterious cytokine, might actually contribute to repair of the synthesis of other cytokines and other substances or even through potentially beneficial effects of the proinflammatory PNS, and IL-1RA, its natural antagonist, might be harmful, at least at certain stages of a disease. cytokines themselves.
IL-1 can induce synthesis of neurotrophic factors (e.g., nerve growth factor) by Schwann cells [12, 83, 84] . Schwann cells Cytokines and Schwann Cell Repair also make ciliary neurotrophic factor [85] , although they do not seem to respond to this growth factor/cytokines by proliferThe PNS has the capacity for repair and regeneration, which partly explains the recovery, albeit variable, in patients with ating. Ciliary neurotrophic factor and leukemia inhibitory factor [86] have some similarity to IL-6 and share some peptide chains self-limited disorders (e.g., GBS or trauma) or diseases in which ongoing damage can be prevented or limited by treatof their receptors with IL-6 [87] . Schwann cells have been shown to synthesize IL-6 [88 -91] . IL-1 has also been shown ment. Two important processes for recovery from damage to the PNS are proliferation of Schwann cells or Schwann cell to up-regulate mRNA for leukemia inhibitory factor in axotomized sensory ganglia [92] . While IL-6 is not directly stimulaprecursors [71 -74] and remyelination. These are important not only in a demyelinating neuropathy but in axonopathies as well tory of Schwann cell proliferation in vitro, it does seem to have co-mitogenic activity for Schwann cells [93] . since axonopathies are accompanied by secondary demyelination and Schwann cells produce cytokines (vide infra) and
Other cytokines/growth factors might also contribute to PNS recovery by inducing Schwann cell migration and differentianeuronal growth factors. Proliferation of Schwann cells also / 9d36$$de14
10-24-97 14:27:42 jinfa UC: J Infect tion as well as proliferation. TGF-b has now been shown to that could potentially be toxic to axons and perhaps explain some of the secondary demyelination seen in severe and recurinduce proliferation of Schwann cells grown in the absence of neurons and axons [94 -98] . In the presence of neurites, the rent demyelinating neuropathies. In addition, the damage to or loss of Schwann cells that are making important trophic factors response of Schwann cells to TGF-b is less clear [67, 68, 99] . Our group has recently found that TGF-b may act as a cofor neurons and axons could also contribute to axonal loss. mitogen with IL-1 for Schwann cells [97] . Thus, TGF-b, which is present in inflammatory lesions (e.g., in GBS [63] ) and is
It Is All a Matter of Timing developmentally regulated in the developing PNS [69], may
It is clear that we need to learn much more about the effects prove to be an important factor in recovery of the PNS from of cytokines on Schwann cells, using purified Schwann cell damage by encouraging proliferation, migration, and differenticultures, dorsal root ganglion cultures, and neuronal-Schwann ation of the Schwann cells and by limiting myelin protein and cell co-cultures. Since single cytokines and chemokines do not glycolipid production. Schwann cells proliferate in response occur in isolation in tissue in inflammatory lesions in humans to platelet-derived growth factor [78] , which is an important and in animal models, the interactions between these cytokines mediator of the activities of other cytokines, including IL-1, and the effects of unfractionated cytokines also need to be in other cell types.
studied. The pathways involved in signaling by these cytokines need to be studied in Schwann cells since important signaling pathways may differ for the same cytokine in different cell Synthesis of Cytokines by Schwann Cells types. Thus, the pathways that are important in Schwann cells Although many cytokines, especially those associated with may be different than those that are important in inflammatory inflammatory and immune reactions, were originally thought cells (lymphocytes and monocytes), oligodendrocytes, astroto be synthesized exclusively by inflammatory cells, it is now cytes, or microglia. The results from in vivo situations need to well established that this is not the case. Glial cells, including be compared with those of in vitro experiments. As pointed the microglia (which are part of the macrophage lineage) and out by Lisak [102] in examining the effects of different cytothe macroglia (oligodendrocytes and especially astrocytes), kines on Schwann cells and in diseases of the PNS, a cytokine have also been reported to synthesize many of these proteins that may contribute to the pathogenesis of a lesion may at other when appropriately stimulated [1, 5] . It has been reported that times be protective and even contribute to repair. Lisak [2] and Schwann cells can synthesize IL-1, although the isoform could others [5] have found the same cytokine effects in diseases of not be specified [100] , and more recently, they have been shown the CNS and with CNS glia. The challenge is to sort out these to synthesize IL-6 [88 -91] , TNF-a [44, 91, 101] , and TGF-b relationships and then to work out paradigms to inhibit disease [63, 64, 69] . Our laboratory has shown that Schwann cells can and encourage repair. This will not be easy since cytokines also increase signal for IL-1RA [58, 59] and presumably also are so pleiotropic, share receptors, have overlapping but not synthesize product. Thus, autocrine and paracrine IL-1 signalidentical properties on different cells, can induce or inhibit the ing and response to the IL-1 family can be seen in Schwann induction of other cytokines, can synergize with or inhibit the cells. Our laboratory has also demonstrated that Schwann cells actions of other cytokines, and in several instances, occur in up-regulate mRNA specific for type I IL-1 receptor [58, 59] , more than one isoform. These overlapping relationships conand since exogenously supplied IL-1RA inhibits unfractionated tribute to the difficulty in obtaining simple answers when using cytokine-induced Schwann cell proliferation, we have evidence knock-out mouse models, although these relationships freof the presence of functional product, the receptor itself. Therequently are useful when taken in the context of data obtained fore, the timing of the appearance of different cytokines sein more classic in vitro and in vivo models. creted by Schwann cells, as well as by infiltrating cells, may be important in PNS repair.
Conclusions
GBS is an inflammatory disorder with various amounts of Cytokines, Schwann Cells, and Axons demyelination and secondary or primary axonal damage. Cytokines released by inflammatory cells and by Schwann cells Damage to axons is a feature of many diseases of the PNS and is often the major limitation in recovery. Therefore, an likely contribute to the pathogenesis of the disorder but may also be involved in protection and recovery from this syndrome. important area for future research should be the effects of cytokines made by the infiltrating cells and Schwann cells on These same proteins are also likely to prove important in other PNS disorders. axons. There is compelling evidence that Schwann cell function is important in repair of axons damaged in Wallerian degeneration and presumably in axonal damage in immune-mediated 
